We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
WB
376
WesBanco Bank
West Virginia
$7.27M +$2.96M +19,220 +73%
SCI
377
S&CO Inc
Massachusetts
$7.26M -$77K -500 -1%
PCA
378
Private Capital Advisors
Connecticut
$7.24M +$27K +175 +0.4%
AIP
379
ARS Investment Partners
New York
$7.19M -$41.3K -268 -0.6%
NSAM
380
North Star Asset Management
Wisconsin
$7.15M -$128K -828 -2%
Flossbach Von Storch
381
Flossbach Von Storch
Germany
$7.15M +$1.22M +7,900 +21%
ZIG
382
Zurich Insurance Group
Switzerland
$7.08M -$1.15M -7,475 -14%
DHFB
383
Dixon Hubard Feinour & Brown
Virginia
$7M +$61.6K +400 +0.9%
RU
384
RobecoSam USA
New York
$6.91M -$1.81M -11,721 -21%
RSS
385
Rosenblum Silverman Sutton
California
$6.89M -$107K -695 -2%
RIM
386
Reliant Investment Management
Tennessee
$6.89M +$3.52M +22,865 +104%
LRPA
387
L. Roy Papp & Associates
Arizona
$6.71M -$132K -858 -2%
KIC
388
Keating Investment Counselors
Florida
$6.58M -$104K -675 -2%
HVIA
389
Hudson Valley Investment Advisors
New York
$6.58M -$107K -697 -2%
SCCM
390
Schafer Cullen Capital Management
New York
$6.41M -$52.4K -340 -0.8%
CIP
391
Chartwell Investment Partners
Pennsylvania
$6.36M
HHMI
392
Howard Hughes Medical Institute
Maryland
$6.36M
NMERB
393
New Mexico Educational Retirement Board
New Mexico
$6.34M -$925K -6,000 -13%
MKC
394
M. Kraus & Co
Vermont
$6.3M -$155K -1,009 -2%
CT
395
Coastline Trust
Rhode Island
$6.28M -$148K -960 -2%
SAM
396
Securian Asset Management
Minnesota
$6.25M +$94.3K +612 +2%
NMIMC
397
Northwestern Mutual Investment Management Company
Wisconsin
$6.2M +$3.7M +23,991 +160%
WIC
398
Whitegate Investment Counselors
New Hampshire
$6.16M -$450K -2,920 -7%
EAM
399
EULAV Asset Management
Florida
$6.14M +$48.4K +314 +0.8%
WAM
400
World Asset Management
Michigan
$6.12M +$125K +813 +2%

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.